Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion Pharmaceutical Investing
Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure Pharmaceutical Investing
Merck's Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy Life Science Investing
Merck's MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study Life Science Investing
Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets Pharmaceutical Investing
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems Pharmaceutical Investing
US FDA Approves Intramuscular Administration for Merck's MMRV Family of Vaccines: M-M-RII , VARIVAX , and ProQuad Life Science Investing
Late-Breaking Data from Landmark COAPT Trial Show Long-Term Benefits of Abbott's MitraClip Device Pharmaceutical Investing
New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval of Reblozyl® for Anemia in Adult Patients with Non-Transfusion-Dependent Beta Thalassemia Pharmaceutical Investing
